3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
CNS
1
Conditions
Brain Neoplasms
4
Radiation Injuries
1
Prostatic Neoplasms
1
Pituitary Neoplasms
1
Neuroendocrine Tumors
1
Multiple Myeloma
1
Meningioma
1
Lymphoma, B-Cell
1
Lymphoma
1
Liver Neoplasms
1
Liver Diseases
1
Glioma
1
Fibrosis
1
Fatigue
1
Colorectal Neoplasms
1
Cognitive Dysfunction
1
Carcinoma, Hepatocellular
1
Cancer Related Cognitive Difficulties
1
Breast Neoplasms
1
Interventions
Magnetic Resonance Spectroscopy
6
lutetium Lu 177 dotatate
4
Specimen Handling
4
Proton Therapy
3
Bevacizumab
3
gallium Ga 68 dotatate
2
abemaciclib
2
Protons
2
Observation
2
Ga(III)-DOTATOC
2
Everolimus
2
Elasticity Imaging Techniques
2
trametinib
1
regorafenib
1
pembrolizumab
1
olaparib
1
neratinib
1
fludarabine
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
capivasertib
1
cabozantinib
1
brigatinib
1
auricularum
1
apatinib
1
X-Rays
1
Watchful Waiting
1
Thrombectomy
1
Tablets
1
Surveys and Questionnaires
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Meningioma
×
Neuropsychological Tests
×
Clear all
NCT05727605
2024-05-08
NARCiS
Universitaire Ziekenhuizen KU Leuven
Phase NA
Recruiting
120 enrolled